BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7696531)

  • 1. A comparative study of meso- and rac-2,3-dimercaptosuccinic acids and their zinc complexes in aqueous solution.
    Fang X; Fernando Q
    Chem Res Toxicol; 1994; 7(6):770-8. PubMed ID: 7696531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformations of zinc chelates of meso- and rac-2,3-dimercaptosuccinic acid in aqueous solution.
    Fang X; Fernando Q
    Chem Res Toxicol; 1994; 7(6):882-90. PubMed ID: 7696547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
    Fang X; Hua F; Fernando Q
    Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning.
    Fang X; Fernando Q
    Chem Res Toxicol; 1995 Jun; 8(4):525-36. PubMed ID: 7548732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure, and properties of rac-2,3-dimercaptosuccinic acid, a potentially useful chelating agent for toxic metals.
    Fang X; Fernando Q
    Chem Res Toxicol; 1994; 7(2):148-56. PubMed ID: 8199302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead chelates of meso- and racemic-dimercaptosuccinic acid.
    Rivera M; Aposhian HV; Fernando Q
    J Inorg Biochem; 1989 Dec; 37(4):283-93. PubMed ID: 2560792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats.
    Jones MM; Singh PK; Kostial K; Blanusa M; Piasek M; Restek-Samarozija N
    Pharmacol Toxicol; 1997 Apr; 80(4):182-6. PubMed ID: 9140137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure, and stability of the zinc complex of the dimethyl ester of meso-2,3-dimercaptosuccinic acid.
    Rivera M; Fernando Q
    Chem Res Toxicol; 1992; 5(1):142-7. PubMed ID: 1316187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
    Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
    Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
    Rivera M; Zheng W; Aposhian HV; Fernando Q
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
    Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilisation of cadmium by meso- and racemic-2,3-dimercaptosuccinic acid (DMSA) in rats.
    Blanusa M; Kostial K; Restek-Samarzija N; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 2000 Oct; 87(4):179-81. PubMed ID: 11097272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
    Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
    J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DL- and meso-dimercaptosuccinic acid: in vitro and in vivo studies with sodium arsenite.
    Aposhian HV; Hsu CA; Hoover TD
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):206-13. PubMed ID: 6306868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
    Zhu X; Lever SZ
    Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of radioactive lead complexes utilizing Chelex methodology.
    Lever SZ; Stricklin DL
    Nucl Med Biol; 1996 Nov; 23(8):1013-7. PubMed ID: 9004291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
    Awh OD; Kim JR; Shim SC
    Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of Cd²⁺ complexes in solution with DMSA and DMPS.
    Zeini Jahromi E; Gailer J; Pickering IJ; George GN
    J Inorg Biochem; 2014 Jul; 136():99-106. PubMed ID: 24367995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
    Aposhian HV; Aposhian MM
    Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.